Home
About
Overview
Sharing Data
ORCID
Help
History (1)
ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s.
ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s. Mucosal Immunol. 2018 01; 11(1):61-70.
View in:
PubMed
subject areas
Acute Lung Injury
Animals
Bleomycin
Cells, Cultured
Disease Models, Animal
Gene Expression Regulation
Humans
Idiopathic Pulmonary Fibrosis
Inducible T-Cell Co-Stimulator Protein
Interleukin-5
Lymphocytes
Mice
Mice, Inbred C57BL
Mice, Knockout
Th2 Cells
authors with profiles
Mary Elizabeth Strek
Anne I. Sperling
Ayodeji Adegunsoye
Melissa Tjota